News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
sede oryzon
ORYZON strengthens patent portfolio for vafidemstat with new Decision to Grant in Japan
Healthcare · Industrial biotechnology
For the treatment of aggression and social withdrawal.
Logo de N-GENE
When genetics does not change, but science does. The challenge of keeping genetic health information up to date
Healthcare · Personalized medicine
A person's genetics do not change throughout their life. What does change, and does so constantly,…
Natac incrementa un 66,5% su EBITDA en 2025, hasta superar los 23 millones
Natac increases its EBITDA by 66.5% in 2025, surpassing €23 million
Corporate
The figure is significantly above the €20 million previously forecast and communicated to the…
Laboratorio de Archivel Farma
Archivel Farma renews GMP certification and strengthens its transformation into a CDMO
Healthcare · Access to innovation
The GMP renewal is the result of a comprehensive process to upgrade the facilities, manufacturing…
Camillas de hospital
The future of Clinical Trials
Healthcare · Access to innovation
Digital transformation and artificial intelligence are redefining the traditional model of clinical…
Científica analizando muestras en un laboratorio
High-Throughput Peptide Library Platform Enables Faster and More Efficient Early Peptide Discovery
Healthcare
Peptide therapeutics are one of the fastest-growing drug classes—but traditional synthesis methods…
Reunión de personas
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Healthcare
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination…
Hombre simulando un infarto de miocardio
BCN HEALTH publishes a study highlighting the substantial productivity losses associated with acute myocardial infarction mortality in Spain
Healthcare
During the study period, an average of 14,6693 people died annually from acute myocardial…
Equipo de Virofend recogiendo el Premio Impulsa Salamanca
ViroFend Therapeutics receives a Salamanca Impulsa Award for its contribution to the biotech ecosystem
Talento
Since its inception, ViroFend has focused on building an organization capable of translating a…